. . . . . .

Vitasang |

CLINICAL TRIAL STARTS IN

Welcome to Vitasang Renew: Revolutionising Ageing, One Innovation at a Time.


About us

Revolutionising Ageing, One Innovation at a Time

Welcome to Renew, part of the Vitasang Group of Companies. Renew is a pioneering lifesciences company that is dedicated to reshaping the future of anti-ageing and rejuvenation technologies. Our mission is to challenge the boundaries of ageing, leveraging our expertise to repurpose known drugs, discover groundbreaking anti-ageing compounds, and bring transformative discoveries to market.

Our top-tier healthcare team, renowned for their contributions to anti-ageing research and communication, is at the forefront of this exciting journey. With the anti-ageing market projected to reach $421 billion by 2030, and an increasing global population embracing anti-ageing solutions from as young as 25, the potential for impact is immense.

Renew is making significant strides in R&D and manufacturing, focusing initially on two revolutionary anti-ageing technologies: Rapamycin, with its remarkable potential to decelerate the ageing process by inhibiting mTOR, and Rejuvesol, a proprietary innovation by Vitasang, designed to rejuvenate cells by improving oxygenation, nutrient delivery, and waste removal. Join us at Renew, where we’re not just envisioning a future of extended youthfulness and vitality, we’re creating it.

Our Team

Ready to execute

Rejuvesol

Leading the Charge in Blood-Based Anti-Ageing and Rejuvenation

Rejuvesol is the only FDA-approved product dedicated to rejuvenating stored red cells, revolutionising the approach to extending the vitality of blood transfusions. This unique technology is the first of its kind to modify red cell quality after the development of a storage lesion, thereby enhancing the RBCs' capacity to deliver oxygen efficiently and navigate through the smallest blood vessels. By restoring 2-3 DPG and ATP levels to those of fresh blood or higher, Rejuvesol optimises the life-sustaining functions of stored red cells.


The Intriguing Connection Between Blood and Ageing

What if the secret to reversing the ageing process lies within our blood? Emerging research sheds light on how our experiences imprint methylation marks on our DNA, serving as indicators of age. These marks, accumulating over time, offer insights into the pace of ageing, presenting a novel approach to understanding how we age biologically.

Unveiling Research Insights

Groundbreaking mice studies have unveiled that exposure to aged circulation can precipitate biological ageing. Remarkably, the removal of old circulation reversed these effects, aligning the mice's biological age with their chronological age. This discovery suggests the potential for reversing ageing by manipulating blood composition.

The Role of Rejuvesol in Ageing Reversal

Rejuvesol-treated red blood cells and plasma could hold the promise of not just slowing the ageing process but potentially reversing it. By enhancing oxygenation, nutrient delivery, and waste removal, Rejuvesol-treated cells could foster cellular vitality and mitigate the effects of ageing. The reduction or elimination of cell stressors through Rejuvesol treatment might pave the way for a revolutionary approach to decelerating the ageing process.

A Future Defined by R&D

Our partnership with Duke University's renowned ageing researchers, Prof. Jim White and Prof. Gurpreet Baht, underscores our commitment to understanding and combating the complexities of ageing. Renew is at the forefront of exploring how Rejuvesol can be integrated into this intricate puzzle, aiming to transform the future of anti-ageing therapy and regenerative medicine.

Rapamycin

Pioneering the Future of Anti-Ageing Therapy

In the quest to turn back the clock on ageing, Renew has embarked on an ambitious collaboration with renowned ageing researcher Prof. Matt Kaeberlein and the influential social media commentator and clinician, Dr. Brad Stanfield. This partnership is centred around an approved clinical trial in New Zealand that explores the efficacy and identifies the optimal safe dosing of Rapamycin for human use, a compound with significant potential in the realm of anti-ageing.


Unlocking Anti-Ageing Secrets at the Cellular Level

Rapamycin's journey from a simple compound to a beacon of hope in anti-ageing science has been driven by its remarkable effects across various species. From yeast to mice, Rapamycin has demonstrated the ability to extend lifespan by inhibiting the mTOR pathway, a crucial regulator of cellular growth and metabolism. This pathway's modulation offers a promising avenue for not just extending life but enhancing the quality of life by delaying the onset of age-related diseases such as Alzheimer's and cardiovascular diseases as well as slowing muscle loss.

Beyond Ageing: The Broad Spectrum of Benefits

The potential benefits of Rapamycin extend well beyond its anti-ageing properties:

  • Autophagy Promotion: Rapamycin aids in the process of autophagy, where cells degrade and recycle their damaged components. This process is vital for preventing cellular damage and the onset of diseases.
  • Immune System Enhancement: Despite being an immunosuppressant, Rapamycin, in smaller doses, has shown potential to bolster immune function in the elderly, offering a dual benefit of disease prevention and immune system rejuvenation.

Navigating the Path Forward: Considerations and Challenges

While the promise of Rapamycin is undeniable, several considerations and challenges remain in fully harnessing its potential:

  • Optimal Dosing: Finding the balance between maximising benefits and minimising known side effects is a critical area of ongoing research.
  • Long-Term Effects: The implications of prolonged Rapamycin use are still largely unknown, necessitating further research to understand its long-term safety and effectiveness.
  • Human Trials: Despite encouraging results in animal models, limited human trials have been conducted. This is why the Renew clinical trial is required in order to confirm Rapamycin's efficacy and safety in humans.
Contact Us

Get in touch

USA

Vitasang Limited
c/o Scott King
2340 Chartres Street
New Orleans,
LA 70117
USA
Email: info@vitasang.com

UK

Vitasang Limited
c/o Ascot Drummond
Devonshire House
Manor Way
Borehamwood
Hertfordshire
WD6 1QQ
UK
Email: antony@vitasang.com

* Required fields

Being the first to know always feels great...

Sign up to our newsletter for the latest updates on Renew, our R&D, and other great content.